focus -WSS

focus

author：Wikipedia 2025-09-29 11:20:28 - browse：85496

A crowd of miniature figurines facing towards an hourglass. -- cancer coverage from STAT — Adobe

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have been dragged through time tied to a metaphorical garbage truck. Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

There’s been a proliferation of various biological aging clocks, mathematical models that look at things like genetic markers or proteins in your body to make some estimation of an individual’s biological age. Research interest in using these clocks has exploded. In the last five years, thousands of papers on or incorporating the clocks have been published. The paper describing one popular biological aging clock, PhenoAge, has over 1,800 citations alone. One recent study suggested that a reason cancer incidence is increasing among younger adults may be accelerated aging, based on this particular clock.

But as scientists use these clocks to associate biological age with specific health risks, like cancer or dementia, and numerous companies eagerly offer biological age measurements in exchange for hundreds of bucks, it may be worth noting that experts don’t agree on what “biological age” actually is.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Readout Newsletter: The latest at Gilead, Catalent, and the NIH

hotspot

focus

WSS

Weight loss drugs aren’t covered by Obamacare. That may change

PBM reforms clear House panel

As AI regulations shape up, health tech startups beg for clarity

MD Anderson's Padmanee Sharma responds to research credit suit

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Alkermes shareholders re

Gain of function research would be limited under House proposal

Walensky prepares to leave CDC — and Congress — behind

As AI regulations shape up, health tech startups beg for clarity

Anesthesiologist group: stop taking Ozempic before surgery

A daunting task: navigating dual Medicare, Medicaid eligibility

Hollywood unions extend contract negotiations for actors

Why medical students are struggling with mental health

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: A CRISPR milestone, biotech mixology

focus

Morphosys mixed study results for blood cancer drug

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Surprise medical billing ban raises prices elsewhere

A new drug could help frostbite victims avoid its ravages

Wegovy, Zepbound and weight loss drugs that preserve muscle

entertainment

hotspot

focus

hotspot